Search the site

Post Doctoral Fellow - Skin Infection Research

Assist in the management of a research project to document the concurrent burden of Group A Streptococcus (GAS) skin infection & GAS pharyngitis

National guideline to tackle record rates of skin infection

Researchers have developed the first National Healthy Skin Guideline to address record rates of skin infections in Australia’s Indigenous communities.

$20 million partnership a win for WA kids

In the largest donation in Telethon history, BHP Billiton has committed $20 million over the next five years to The Kids Research Institute Australia

Ear Explorers: A ‘real-life research project’ enabling children to view inside their own ears using smartphone video-otoscopy

Chris Brennan-Jones PhD Head, Ear and Hearing Health chris.brennan-jones@thekids.org.au Head, Ear and Hearing Health Professor Chris Brennan-Jones is

Infants removed by Child Protection: Nature, extent and impact

This study aims to increase knowledge about the nature, extent and impact of removals, repeat removals and entries of new babies into the care system.

WATCH: Working Together after the referendum

Professor Helen Milroy, Michael Mitchell, and Professors Roz Walker and Pat Dudgeon sat on the panel to discuss Working Together, 10 years on.

Writing our story for Wear It Purple Day

Embrace @ The Kids Research Institute Australia celebrates Wear It Purple Day with Rio Tinto

Modelling Micro-Elimination: Third-Trimester Tenofovir Prophylaxis for Perinatal Transmission of Hepatitis B in the Remote Dolpa District of Nepal

Hepatitis B (HBV) prevalence is very high in pregnant women in the Dolpa district of Nepal, a region characterised by a remote geographic landscape and low vaccination coverage. Using mathematical modelling, we evaluated the impact of third-trimester tenofovir disoproxil fumarate (TDF) prophylaxis on HBV burden and estimated the time required to achieve HBV elimination in Dolpa.

Intranasal phage therapy overcomes antibody neutralization challenges in pulmonary Pseudomonas aeruginosa infections

Phage therapy is a promising approach against multidrug-resistant infections, yet systemic administration can lead to incomplete cures. We investigated the distribution, immune responses, and efficacy of the therapeutic phage KPP10 delivered via intranasal or intraperitoneal routes in murine Pseudomonas aeruginosa lung infection models.

Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease

Mycobacteroides abscessus (MABS) is within the non-tuberculous mycobacteria family. It inhabits soil and water, exhibits multi-antibiotic resistance and causes opportunistic lung infections, which may progress to symptomatic MABS-pulmonary disease (MABS-PD) associated with substantial morbidity, increased healthcare utilisation, impaired quality of life and increased mortality.